Results 151 to 160 of about 17,596 (164)

Aspects of depolarizing neuromuscular blockers: decamethonium and suxamethonium

Paediatric anaesthesia, 2013
T. Brown
semanticscholar   +1 more source

Neuromuscular blockers in surgery and intensive care, Part 2.

American Journal of Health-System Pharmacy, 2001
M. McManus
semanticscholar   +1 more source

Nondepolarizing Neuromuscular Blocking Agents

, 2017
Erin Bettendorf, Zhilin Xiong
semanticscholar   +1 more source

Reexamined: The Recommended Endotracheal Intubating Dose for Nondepolarizing Neuromuscular Blockers of Rapid Onset

Survey of Anesthesiology, 2003
openaire   +1 more source

Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit.

Critical Care Medicine, 1996
M. Rudis, B. Guslits, Edward L. Peterson, Stephen J. Hathaway, E. Angus, S. Beis, B. Zarowitz   +6 more
semanticscholar   +1 more source

Comparison of hemodynamic and neuromuscular properties of rocuronium versus vecuronium in anesthesia

, 2016
U. Rao
semanticscholar   +1 more source

Sugammadex: A Novel Agent for the Reversal of Neuromuscular Blockade

Pharmacotherapy, 2007
W. Nicholson, J. Sprung, C. Jankowski
semanticscholar   +1 more source

Rocuronium-Induced Neuromuscular Blockade Is Affected by Chronic Phenytoin Therapy

Journal of Neurosurgical Anesthesiology, 2001
J. Hernández‐Palazón, J. A. Tortosa, J. Martínez-Lage, M. Pérez‐ayala   +3 more
semanticscholar   +1 more source

Update on neuromuscular pharmacology

Current Opinion in Anaesthesiology, 2009
M. Naguib, S. Brull
semanticscholar   +1 more source

Atracurium–induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine

Acta Anaesthesiologica Scandinavica, 1997
A. Spacer, F. Neiger, C. Spiss, H. Kress
semanticscholar   +1 more source